Cited by 92Regulation of Appetite and ObesityAdipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and Metabolism

Acute intravenous leptin infusion increases glucose turnover but not skeletal muscle glucose uptake in ob/ob mice.

Burcelin, R, Kamohara, S, Li, J, Tannenbaum, G S, Charron, M J, Friedman, J M·1999·Diabetes

Abstract

The mouse ob gene encodes leptin, an adipocyte hormone that regulates body weight and energy expenditure. Leptin has potent metabolic effects on fat and glucose metabolism. A mutation of the ob gene results in mice with severe hereditary obesity and diabetes that can be corrected by treatment with the hormone. In lean mice, leptin acutely increases glucose metabolism in an insulin-independent manner, which could account, at least in part, for some of the antidiabetic effect of the hormone. To investigate further the acute effect of leptin on glucose metabolism in insulin-resistant obese diabetic mice, leptin (40 ng x g(-1) x h(-1)) was administered intravenously for 6 h in C57Bl/6J ob/ob mice. Leptin increased glucose turnover and stimulated glucose uptake in brown adipose tissue (BAT), brain, and heart with no increase in heart rate. A slight increase in all splanchnic tissues was also noticed. Conversely, no increase in skeletal muscle or white adipose tissue (WAT) glucose uptake was observed. Plasma insulin concentration increased moderately but neither glucose, glucagon, thyroid hormones, growth hormone, nor IGF-1 levels were different from phosphate-buffered saline-infused C57Bl/6J ob/ob mice. In addition, leptin stimulated hepatic glucose production, which was associated with increased glucose-6-phosphatase activity. Conversely, PEPCK activity was rather diminished. Interestingly, hepatic insulin receptor substrate (IRS)1-associated phosphatidylinositol 3-kinase activity was slightly elevated, but neither the content of glucose transporter GLUT2 nor the phosphorylation state of the insulin receptor and IRS-1 were changed by acute leptin treatment. Hepatic lipid metabolism was not stimulated during the acute leptin infusion, since the content of triglycerides, glycerol, and citrate was unchanged. These findings suggest that in ob/ob mice, the antidiabetic antiobesity effect of leptin could be the result of a profound alteration of glucose metabolism in liver, BAT, heart, and consequently, glucose turnover. Insulin resistance of skeletal muscle and WAT, while not affected by acute leptin treatment, could also be corrected in the long term and account for some of leptin's antidiabetic effects.

Integrity signals

Registry

Crossref · 10.2337/diabetes.48.6.1264

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In ob/ob mice, intravenous leptin increases glucose turnover and stimulates glucose uptake in brown adipose tissue, brain, and heart, but not in skeletal muscle or white adipose tissue.

    “In ob/ob mice, i.v. leptin also increased glucose turnover and stimulated glucose uptake in brown adipose tissue (BAT), brain and heart, but not in skeletal muscle or white adipose tissue (WAT) (29).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Burcelin, R., Kamohara, S., Li, J., Tannenbaum, G. S., Charron, M. J., & Friedman, J. M.
Affiliations
Albert Einstein College of Medicine (US)
Venue
Diabetes
Published
1999-06-01
Volume
48
Issue
6
Pages
1264-1269
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2127314379
Cited by
92
References
13
Citations by year
2026: 1 · 2025: 2 · 2024: 4 · 2022: 2 · 2021: 2 · 2019: 1 · 2017: 3 · 2016: 2 · 2015: 5 · 2014: 2 · 2012: 4
FWCI
2.78
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
Keywords
leptin, ob/ob mice, glucose turnover, skeletal muscle glucose uptake, hepatic glucose production, glucose-6-phosphatase, phosphoenolpyruvate carboxykinase, insulin resistance, IRS-1, phosphatidylinositol 3-kinase, white adipose tissue, antidiabetic effect, obesity
MeSH terms
Animals, Electrocardiography, Female, Glucagon, Gluconeogenesis, Glucose, Heart Rate, Infusions, Intravenous, Insulin, Insulin-Like Growth Factor I, Liver, Mice, Inbred C57BL, Mice, Obese, Obesity, Proteins, Growth Hormone, Muscle, Skeletal, Leptin, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review